ES2057021T3 - Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta. - Google Patents

Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.

Info

Publication number
ES2057021T3
ES2057021T3 ES89109891T ES89109891T ES2057021T3 ES 2057021 T3 ES2057021 T3 ES 2057021T3 ES 89109891 T ES89109891 T ES 89109891T ES 89109891 T ES89109891 T ES 89109891T ES 2057021 T3 ES2057021 T3 ES 2057021T3
Authority
ES
Spain
Prior art keywords
shredding
tablet
pharmaceutical dosage
manufacturing
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89109891T
Other languages
English (en)
Inventor
Scoik Kurt Gard Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2057021T3 publication Critical patent/ES2057021T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UNA DOSIFICACION FARMACEUTICA EN TRITURADO DE TABLETA. LA FORMA DEL TRITURADO DE TABLETA INCLUYE UNA RED AMALGAMADORA CONSTITUIDA POR UN CARBOHIDRATO SOLUBLE EN AGUA PERO INSOLUBLE EN ETANOL. TAMBIEN SE INCLUYEN PARTICULAS DISCRETAS DE UN SOLIDO, INGREDIENTE ACTIVO SOLUBLE EN AGUA PERO INSOLUBLE EN TRIGLICERIDO, UN POLIMERO, UN EMULSIFICADOR Y BICARBONATO DE SODIO MEDIANTE EL CUAL LAS PARTICULAS DISCRETAS TIENEN UN REVESTIMIENTO TRIGLICERIDO.
ES89109891T 1988-06-07 1989-06-01 Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta. Expired - Lifetime ES2057021T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20339688A 1988-06-07 1988-06-07
US35279989A 1989-05-18 1989-05-18

Publications (1)

Publication Number Publication Date
ES2057021T3 true ES2057021T3 (es) 1994-10-16

Family

ID=26898571

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89109891T Expired - Lifetime ES2057021T3 (es) 1988-06-07 1989-06-01 Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.

Country Status (5)

Country Link
EP (1) EP0345628B1 (es)
JP (1) JP2940937B2 (es)
CA (1) CA1335257C (es)
DE (1) DE68906461T2 (es)
ES (1) ES2057021T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69212497T2 (de) * 1991-12-05 1996-12-12 Mallinckrodt Veterinary Inc Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
HU219349B (en) 1991-12-24 2001-03-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation and production thereof
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
JP4808392B2 (ja) * 2003-09-04 2011-11-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 苦味を隠蔽する薬理組成物
JP6772419B2 (ja) 2016-05-13 2020-10-21 株式会社神戸製鋼所 密閉型混練機に備えられているダストストップ装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE3432974A1 (de) * 1983-09-12 1985-04-04 The Upjohn Co., Kalamazoo, Mich. Arzneimittel zur prophylaxe oder therapie der negativen shizophreniesymtome bei menschen
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
CA1311686C (en) * 1986-06-25 1992-12-22 John Weldon Shell Controlled release bioerodible drug delivery system
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance

Also Published As

Publication number Publication date
DE68906461D1 (de) 1993-06-17
EP0345628B1 (en) 1993-05-12
JPH0232014A (ja) 1990-02-01
EP0345628A2 (en) 1989-12-13
CA1335257C (en) 1995-04-18
JP2940937B2 (ja) 1999-08-25
EP0345628A3 (en) 1990-12-27
DE68906461T2 (de) 1993-10-21

Similar Documents

Publication Publication Date Title
Langer et al. Medical applications of controlled release
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
MX9308188A (es) Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida.
AR021443A1 (es) Formulacion de liberacion controlada de divalproex sodio
AR040722A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
ATE232091T1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
DE69637441D1 (de) Verabreichung unlöslicher arzneistoffe
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
DE69419492D1 (de) Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung
MX10086A (es) Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion.
ES2173891T3 (es) Sistema de liberacion pulsatil de un farmaco multiparticulado.
CY1105908T1 (el) Στοματικως αποσαθρουμενα δισκια που πepιλαμβανουν βενζιμιδαζολιο
BR9608785A (pt) Forma de dosagem oral contendo como um princípio ativo um ácido mega-3- poli insaturado uso de um ácido ómega-3-poli insaturado e processo de tratar inflamação intestinal
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
ATE370727T1 (de) Pharmazeutische suspensionstabletten- zusammenstellungen
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
MXPA01002634A (es) Sistema de entrega que controla a una droga oralmente administrada proporcionando control en tiempo y espacial.
DE602004032149D1 (de) Oros-push-stick für die kontrollierte abgabe von wirkstoffen
ES2044825T3 (es) Formulaciones de matriz de liberacion retardada.
PT90466A (pt) Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
ES2142601T3 (es) Comprimido masticable con accion efervescente.
UY25544A1 (es) Forma de dosificación de nefazodona
FR2798289B1 (fr) Formes galeniques a delitement rapide en bouche et leur procede de preparation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 345628

Country of ref document: ES